http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004073608-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ddedb1b264bab717cf2c22e6d9efbaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2692966f2e618e16cbe978b308756bce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdd619b8a2cc2f110b9ee4dc8d896a17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e2448995bd8dd4bd1476f11d772246a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adc435646b1d062c4e65ba41ef7efdb6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
filingDate 2004-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03f2490a7de454c0e08edc9101034c6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f9520f0f346c7c1d1616c689bd9d5f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54bc27930abd7d499ede7ab52fd6cbe4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d38666dd123717cdbe7b9959e3498344
publicationDate 2005-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004073608-A3
titleOfInvention Formulations of glucocorticoids to treat pathologic ocular angiogenesis
abstract Formulations of glucocorticoids alone and in combination with anecortave acetate are useful for preventing and treating pathologic ocular angiogenesis and associated edema.
priorityDate 2003-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5770592-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226471759
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID111332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502635

Total number of triples: 31.